2022 Conference

The 20th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 11-12 May 2022.

The 2022 IOTOD faculty led an engaging two-day meeting, featuring international field experts speaking on multiple and emerging topics, such as: the changing patient profile, opioid analgesic dependence, opioid substitution therapy, the experience so far with long-acting buprenorphine formulations from the patients’ perspectives, and optimising best approaches to address viral hepatitis in PWIDs. 

Session webcasts

Highlights report – Session 5: Viral hepatitis: uncovering the unknown

Faculty

The IOTOD conference partners with internationally-renowned faculty from a variety of backgrounds and specialities.

Professor Catriona Matheson

Professor in Substance Use, University of Stirling

Stirling, UK

Professor Adrian Dunlop

Director and Senior Staff Specialist Hunter New England Local Health District Drug & Alcohol Clinical Services

Newcastle NSW, Australia

Dr Stephan Walcher

Director, Concept Centre for Addiction Medicine

Munich, Germany

Ms Cathryn Kemp

Author of ‘Coming Clean'

UK

Professor Maurice Dematteis

Head of the Department of Addictions, University Hospital of Grenoble

Grenoble, France

Professor Oscar D’Agnone

Consultant Psychiatrist; and Honorary Professor of the Faculty of Medical and Human Sciences, University of Manchester

Manchester, UK

Professor John Marsden

Professor of Addiction Psychology, Addictions Department, King’s College London

London, UK

Mr Duncan Cairns

Chair of the Board of Directors, Aurora Project

London, UK

Professor Nicholas Lintzeris

Director, Drug and Alcohol Services, South East Sydney Local Health District

Sydney, Australia

Dr Michael Frost

President/Medical Director

The Frost Medical Group, Pennsylvania, United States

Mr Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

Glasgow, Scotland

Professor Trish Hafford-Letchfield

Head Of School School of Social Work and Social Policy University of Strathclyde

Glasgow, Scotland

Professor Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Chair – Professor Heino Stöver

Professor of Social Scientific Addiction Research, Frankfurt University of Applied Sciences

Frankfurt, Germany

Professor Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK


Sponsors

The 2022 IOTOD conference is supported by the following companies:

Camurus

Gilead

Accord Healthcare

Molteni Farmaceutici

Indivior

The IOTOD experience

Measuring behavioural changes

2011 marked the year measurement of delegate behavioural changes began. These measurements showed the IOTOD conference elicited measurable significant improvements in physician behaviours over the years, which have been published in the European Journal of CME.

Download

IOTOD’s commitment to change